RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Saxagliptin vs. glipizide as add-on therapy in patients with type 2 diabetes mellitus inadequately controlled on metformin alone: long-term (52-week) extension of a 52-week randomised controlled trial.

Saxagliptin vs. glipizide as add-on therapy in patients with type 2 diabetes mellitus inadequately controlled on metformin alone: long-term (52-week) extension of a 52-week randomised controlled trial.

Add to Collection
2013 Apr RCTs Fist_Author_Year_PM

Full Author : ['Goke, Burkhard', 'Gallwitz, Baptist', 'Eriksson, Johan G', 'Hellqvist, Asa', 'Gause-Nilsson, Ingrid']
Journal Title : International journal of clinical practice
Chapter : Section3
Journal Year : 2013
Cited by : Not Available

AIM: To compare the long-term safety, tolerability and efficacy of saxagliptin vs. glipizide as add-on therapy to metformin. METHODS: Adults with glycated haemoglobin (HbA1c) > 6.5-10% (on stable metformin >/= 1500 mg/day) were randomised to saxagliptin 5.....

Keywords : ["type diabetes mellitus inadequately control", "metformin alone longterm extension", "randomise control trial", "saxagliptin vs glipizide", "addon therapy", "patient"]